Send us a Text Message. This week Dave Knapp covers GLP-1 censorship on TikTok,  the rise of bootleg medication scrutiny, and just how big the GLP-1 market may get in 2024. Email Alerts: https://www.onthepen.com/emails BECOME A MEMBER HERE TO WATCH THE VIDEO: https://www.youtube.com/channel/UCDocQ-4IhVS3ihy_dW7nSKw/join Bloomberg #ReleaseTheVials Feature: https://www.bloomberg.com/news/articles/2024-04-02/zepbound-shortage-patients-push-eli-lilly-to-release-more-obesity-drug-supply Yahoo Finanace #ReleaseTheVials Feature VIDEO: https://youtu.be/nQbYa47DF4Q?feature=shared #mounjaro #zepbound #tirzepatide Bootleg Meds: https://www.reuters.com/business/healthcare-pharmaceuticals/more-than-250-websites-selling-fake-weight-loss-drugs-reported-by-anti-2024-04-15/  Drug Shortage Reporting: https://www.wsj.com/health/healthcare/drug-medication-shortages-us-olympic-amoxicillin-107fa9d8 GLP-1 Sales: https://www.fiercepharma.com/marketing/glp-1s-track-take-drug-sales-crown-pd-1-inhibitors-2024-analyst Support the Show. Thank you for tuning in! If you found this content valuable, make sure to like, share, and subscribe to my youtube channel for more updates on GLP-1, obesity, type 2 diabetes, and the latest news on Mounjaro, Zepbound, Wegovy, and Ozempic. Stay informed and entertained with my unique blend of breaking news, humor, and my personal journey. For in-depth articles and resources, visit my website at onthepen.com. You can also connect with me on social media, where I go by @manonthemounjaro (or @manonmounjaro on X). Let's continue this journey together towards a healthier and happier life!